Present and former group members
Current group members
Camilla Miola
Amela Peco
Former group members
Graduated students PhD
2023 - Camilla Johansson, Proteomic strategies for blood biomarker development in rare dystrophinopathies, KTH (main supervisor),
2018 - Erik Fasterius, Exploring genetic heterogeneity in cancer using high-throughput DNA and RNA sequencing, KTH (main supervisor),
2013 - Gabriel Östlund, Data integration for robust network-based disease prediction, Stockholm University (co-supervisor),
2011 - Kristoffer Forslund, The relationship between orthology, protein domain architecture and protein function, Stockholm University (co-supervisor).
Researchers
2025 - Carla Bolaño Diaz, Biomarker discovery for Limb-Girdle Muscular Dystrophy,
Postdocs
2023 - Sharon de Vries, Development of disease progression biomarkers for Duchenne Muscular Dystrophy,
2018 - Rachele Rossi, Evaluation of biomarkers for Duchenne Muscular Dystrophy,
Undergraduate students' master's level
2025 - Camilla Miola, Development of biomarker assays for quantification of Duchenne Muscular Dystrophy Biomarkers,
2025 - Mario Alejandro Aguilar Velazquez, Optimization of a protocol for an oligonucleotide-mediated methodology to enhance the sensitivity of Duchenne Muscular Dystrophy biomarkers detection in serum samples,
2025 - Sofia Hong,Integrating Binding Oligo Ladder Detection technology with Suspension Bead Array platform for detection of low-abundant biomarkers in Duchenne Muscular Dystrophy,
2024 - Niklas Smed, Quantification assay applicable to suspension bead array based proteomics associated to Muscular Dystrophy,
2023 - Nathalie Lager, Serum protein biomarker assay development – a complexity reduction challenge,
2023 - Aya Ajeenah, Developing a background-controlling immunoassay on suspension bead array technology,
2023 - Petter Nhi, Generation of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in FN-Silk 3D Scaffolds,
2022 - Abigail Michelle De Souza, Discovery of Biomarker Candidates for Becker Muscular Dystrophy,
2021 - Albert, Jimenéz Requena, Biomarker development for early diagnostics of Duchenne Muscular dystrophy
2021 - Elin Gath, Development and validation of biomarker quantification assays for monitoring disease progression in Duchenne muscular dystrophy,
2019 - Patrik Hurtig, Improved thiol-mediated labelling of antibodies through Protein A Immobilization,
2017 - Camilla Johansson, Exploring genotype to phenotype correlations in Duchenne muscular dystrophy,
2017 - Sandra Mena, Protein biomarker analysis in muscular dystrophies,
2016 - Indira Patricia Lopez, Development of immunoassays for muscle dialysis samples from patients affected by Muscular Dystrophy,
2015 - Fidele Karibushi, Development of a bead-based immunoassay for detection of circulating autoantibodies in Duchenne Muscular Dystrophy,
2015 - Kristin Strandberg, Development of Sandwich Immunoassays for detection of muscular dystrophy biomarkers,
2014 - Erik Fasterius, Absolute Protein Quantification of EGFR Network Components by Mass Spectrometry,
2012 - Ravi Teja Ghanta, Identification and selection of novel tobacco etch virus protease variants with tailored specificity,
2011 - Fakhry Mahrous, Mono-specific antibodies can be used for the determination and diagnostics of Minichromosome Maintenance 3 splice variants or other protein splice variants using western blotting,
2010 - Wasil Sriwi, Expression and purification of fusion proteins with cleavable tags,
2008 - Charlotte Stadler, Subcellular localisation of proteins - Using bioinformatics and fluorescence microscopy,
2005 - Charles Goussou, Antibody stability upon prolonged storage,
